| abstract |
The reduction of biological activity and toxicity of biologically active compounds by the conjugation of biologically active compounds with activated polyalkylene glycols having moieties covalently bound to such compounds is described. Pharmaceutical compositions containing polyalkylene glycol conjugates and carriers, and treatments for patients by administration of compositions with polyalkylene glycol conjugates are described. |